BioSpace News Archive

Today, the National Comprehensive Cancer Network® (NCCN®) is debuting the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Acute Lymphoblastic Leukemia (ALL)—the most comprehensive and up-to-date evidence-based, consensus-driven guidelines for treating children with cancer outside of a clinical trial setting.

Colgate-Palmolive’s Prabha Parameswaran, President, Colgate-Europe, will present on Thursday, June 13, 2019 at the dbAccess Global Consumer Conference in Paris at 11:45 a.m. CET (5:45 a.m. ET).

PureTech Health plc. announced that Daphne Zohar, founder and chief executive officer, will present at the Jefferies 2019 Healthcare Conference in New York City on Wednesday, June 5, at 11:30 AM EDT.

In early May, Michael Cartwright, the CEO of American Addiction Centers, outlined his 2030 vision for the company.

Ametros has promoted Nicole Sauk to Chief Financial Officer.

Innovus Pharmaceuticals, Inc. released the final voting results from the Annual Shareholders Meeting held on May 28, 2019.

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it has entered into a strategic collaboration with Debiopharm for the development of a companion diagnostic (CDx) test using its newly-launched Whole Transcriptome Sequencing (WTS) assay for mRNA analysis called MI Transcriptome™

Milestone Pharmaceuticals Inc. announced Joseph G. Oliveto, President and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference in New York on Thursday, June 6, 2019 at 9:30 a.m. Eastern Time.

REGENXBIO Inc. announced it completed dosing across all five cohorts in the Phase I/IIa clinical trial of RGX-314 for the treatment of wet age-related macular degeneration.

Antibe Therapeutics Inc., a leader in developing safer therapeutics for pain and inflammation, is pleased to announce its conference schedule for the upcoming months.